Related Experiment Videos
Use of antibiotics to prevent preterm birth
1Department of Obstetrics and Gynecology, University of Colorado Health Sciences Center, Denver, USA.
Insights
Antibiotics can prevent preterm birth complications when used selectively. Treatment is recommended for bacterial vaginosis and during preterm premature rupture of membranes, but not routinely for all preterm labor cases.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Neonatal Medicine
Background:
- Preterm birth remains a leading cause of neonatal morbidity and mortality.
- Antibiotic use in pregnancy is complex, with potential benefits and risks.
- Current guidelines for antibiotic use in preterm birth prevention require clarification.
Purpose of the Study:
- To review current data on antibiotic use for preventing preterm birth and related complications.
- To provide a clinical opinion on the appropriate application of antibiotics in managing preterm birth.
- To synthesize evidence regarding antibiotic efficacy and safety in specific obstetric scenarios.
Main Methods:
- Comprehensive literature review of recent studies on antibiotic use in preterm birth.
- Synthesis of expert clinical opinion and current evidence-based guidelines.
- Analysis of data related to maternal-neonatal outcomes and antibiotic interventions.
Main Results:
- Screening and treatment for Neisseria gonorrhoeae, Chlamydia trachomatis, and bacteriuria are standard prenatal practices.
- Treat bacterial vaginosis in high-risk patients for preterm birth; do not treat Ureaplasma urealyticum or group B streptococci colonization.
- Antibiotics are indicated for preterm premature rupture of membranes (PPROM) to prolong pregnancy between 24-32 weeks gestation and for bacterial vaginosis and Trichomonas vaginalis treatment.
Conclusions:
- Antibiotic therapy is indicated in selected clinical settings to prolong pregnancy and prevent maternal-neonatal complications associated with preterm birth.
- Routine antibiotic use to prolong pregnancy is not recommended, except in specific conditions like PPROM.
- Vigilance for antibiotic resistance is crucial due to potential adverse effects.
Abstract:
Our purpose is to review recent data and provide a clinical opinion on the use of antibiotics to prevent preterm birth or related maternal-neonatal complications. A literature review and a synthesis of opinion are provided. During prenatal care, standard practices should be applied regarding Neisseria gonorrhoeae, Chlamydia trachomatis, and bacteriuria. In addition, screen for and treat bacterial vaginosis in patients at high risk for preterm birth but do not treat Ureaplasma urealyticum or group B streptococci genital colonization. With preterm labor and intact membranes, standard practices should be applied regarding group B streptococci prophylaxis. Do not give antibiotics routinely to prolong pregnancy, but in patients with bacterial vaginosis and Trichomonas vaginalis specific treatment should be given. With preterm premature rupture of membranes, standard practices should be applied regarding group B streptococci prophylaxis, but additional antibiotics should also be given to prolong pregnancies at 24 to 32 weeks' gestation. Reported adverse effects have been few to date. However, increased diligence is needed for resistant organisms. In selected clinical settings antibiotic therapy is now indicated to prolong pregnancy and prevent maternal-neonatal complications associated with preterm birth.